AffinityImmuno Inc.
$49,337.00 CAD
≈ 8 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- June 1, 2021 – July 31, 2024
- Reference
- nrc-cnrc:172-2021-2022-Q1-973631
Published purpose
Using a bioassay guided fractionation method, AffinityImmuno identified a natural product that is a potent inhibitor of SARS-CoV-2 spike protein binding to ACE2. Research on this natural product is to be accelerated and tested in an series of SARS-CoV-2 permissible cell lines and a hamster model of Covid-19 in order to determine whether to pursue a human health product.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions